Board

Gabriele Ambrosanio, is a Project Manager with proven expertise in the management and coordination of complex research and innovation programs and specialized in project planning, operational execution, and governance, supporting strategic decision-making across multidisciplinary initiatives. He has contributed to the success of MNESYS, a large collaborative neuropharmacological PNRR project launched in 2022; in MNESYS, he has worked closely with academic institutions, industry partners, and public stakeholders to ensure effective collaboration, timely project delivery, and the achievement of scientific and operational objectives.

Alessandro Arvigo, is a Supreme Court Lawyer, with extensive experience in administrative law, public procurement, and complex corporate transactions. Throughout his career, he has advised public authorities, infrastructure companies, multi-utilities, and private enterprises on high-profile regulatory and strategic matters. He currently serves on the boards of directors of strategic companies, providing legal counsel on governance, institutional affairs, and corporate operations.

Giovanni Della Cioppa, MD, is a clinical Research & Development Consultant with over three decades of international experience in the development of innovative medicines and vaccines. He has held senior leadership positions at global pharmaceutical companies, including  ovartis and GSK, leading international clinical development programs from early-stage research through regulatory approval and lifecycle management. He has played a key role in global vaccine initiatives, including government-supported COVID-19 vaccine task forces, and brings extensive expertise in clinical development, regulatory strategy, and translational medicine, supporting the advancement of innovative therapies from discovery to clinical practice.